In the future, this method, potentially combined with cell sorting schemes to resolve lineage preference within the CD34 + fraction53, should help determine whether cells that undergo gene targeting have a bias towards particular lineages which may help guide which human genetic diseases of the blood may be most amenable to gene targeting based approaches. This evidence concerns the gene CD34 and hereditary disease.